Skip to content
2000
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test
Bentham Science Publishers:
http://instance.metastore.ingenta.com/content/journals/cvp/10.2174/0115701611292747231129080204
10.2174/0115701611292747231129080204
SEARCH_EXPAND_ITEM
Benefits of Statins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors for Patients with Peripheral Arterial Disease, Page 1 of 1
< Previous page
|
Next page >
/docserver/preview/fulltext/cvp/22/1/s4-1.gif